This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of targeted cancer therapies. It plays a significant role in the development of tyrosine kinase inhibitors, which are designed to block specific enzymes involved in the growth and proliferation of cancer cells. Its structural features make it a valuable building block for creating molecules that can selectively bind to and inhibit receptors like EGFR (Epidermal Growth Factor Receptor), which is often overactive in various cancers such as lung and colorectal cancer. Researchers also explore its potential in modifying drug candidates to enhance their efficacy, selectivity, and pharmacokinetic properties. Additionally, it may be investigated for its application in treating other diseases where kinase signaling pathways are dysregulated.